Darers & Doers Podcast: The Quest for AI-Powered Cancer Vaccines
Apr.09.2026
Likang Life Sciences founder Chen Li explains how his Beijing startup is developing personalized mRNA cancer vaccines and why China’s biotech rise matters globally
Cancer treatment has long relied on a largely fixed set of options: surgery, radiation, chemotherapy and targeted drugs. But a new generation of biotech founders is trying to push the field toward something more precise — treatments built around the biology of a single patient.
In this debut episode of Darers & Doers, a special segment of the China Business Uncovered podcast, Likang Life Sciences Founder and CEO Chen Li explains how his Beijing-based biotech startup is using artificial intelligence to develop personalized mRNA cancer vaccines.
MORE WAYS TO LISTEN
- 1In Depth: As China’s Hidden Local Debts Shrink, a New Challenge Emerges
- 2Charts of the Day: Huawei Partners’ EV Sales Lead China Upstarts
- 3China Taps Industry Veteran Ding Xiangqun to Lead Top Financial Regulator
- 4EU Fines Temu 200 Million Euros for Letting in Unsafe Products
- 5Analysis: Why China’s Carmakers Fear Falling Behind Without Huawei
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas




